Skip to main content
ALAB logo

Astera Labs, Inc. Common Stock (ALAB) Stock: Price, Forecast & Analyst Target

Astera Labs, Inc. Common Stock (ALAB) — MoonshotScore 87/100 (Exceptional band), calculated Nov 18, 2026. Price $216.75 (+2.43%), as of the Nov 18, 2026 trading session; market cap $37.9B.

Educational signal · not a buy or sell recommendation · How to read this

$216.75 +$5.15 (+2.43%) Market Cap $37.9B

Astera Labs, Inc. Common Stock · ALAB · NASDAQ · Technology · Semiconductors

Research dated 2026-09-13: Astera Labs supplies semiconductor-based data, network and memory connectivity for cloud and artificial intelligence systems; it enables processors and memory to communicate rather than selling the processors that perform the computing. Scorpio’s ramp now has to sustain rapid revenue and profit expansion while the guided gross margin softens and the valuation assumes substantial future growth.

Price as of Nov 18, 2026

Key Statistics

87 of 100

MoonshotScore v2 · Astera Labs, Inc. Common Stock (ALAB)

Exceptional
Business Quality Elite (91)
Financial Safety Fortress (84)
Valuation Bubble (19)
Growth Durability Compounding (98)
Momentum Quiet (59)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality, a strong balance sheet and elite growth, but an expensive valuation. Business Quality: Elite; Financial Safety: Fortress; Valuation: Bubble; Growth Durability: Compounding; Momentum: Quiet.

Enterprise value relative to free cash flow is the main valuation drag relative to sector peers.

  • EPS beat 0 of the last 4 reports
  • Altman Z 74.69 · Piotroski F 5
  • ROE 28.2% · ROA 13.4% · current ratio 8.03

Holding back: a rich price

Helping: business quality, balance-sheet strength, durable growth

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for ALAB (57 recorded, newest six shown)
RecordedScoreBand
82Exceptional
82Exceptional
81Exceptional
81Exceptional
87Exceptional
87Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$216.75
Change on the day+2.43%
52-week range$97.89–$499.48
Market capitalisation$37.9B—
Price / earnings (trailing)78.96
Shares traded on the day4.57M
Beta (volatility vs the S&P 500)3.86

Why Astera Labs, Inc. Common Stock scores 87

Dr. Mira Sol, the Stock Expert AI TV data character
Growth Durability carries the score; Valuation is what holds it back.
Dr. Mira Sol · Data scientist, Stock Expert AI TV (fictional AI character)
87Exceptional
  • Business Quality91
  • Financial Safety84
  • Valuation19
  • Growth Durability98
  • Momentum59

Share price, last 12 months +24.8%

$173.74 $216.87

What the price assumes

30.4% a year of free-cash-flow growth for ten years is what a $37.62B market value ( snapshot) asks for.

  • Price implies, next ten years30.4%
  • Revenue, last 3 years120.2%
  • Analysts' revenue path, 2026–203038.7%

The price asks for less growth than the business has been producing. The question it leaves open is how long that pace lasts, not whether it exists.

Reverse discounted cash flow: 10% discount rate, 3% growth after year ten, starting from trailing twelve months free cash flow of $344.69M. Inputs: FMP statements, estimates and quote.

How the stock reacts to earnings

EPS beat in 11 of the last 12 reports (2024–2026); the stock still fell the next session after 8 of those beats. Average first-session move: 12.4% either way.

  1. +12.8%Mar ’24
  2. -11.3%May ’24
  3. -16.9%Aug ’24
  4. +32.0%Nov ’24
  5. -9.1%Feb ’25
  6. -1.5%May ’25
  7. +26.4%Aug ’25
  8. -5.0%Nov ’25
  9. -23.4%Feb ’26
  10. +6.3%May ’26
  11. -0.8%Aug ’26
  12. -2.8%Nov ’26
Next-session move EPS beat (11) EPS not reported (1)
Every report, with revenue and five-session moves
Moves run from the close before the report to the first and fifth closes after it.
ReportEPSRevenueNext session5 sessions
BeatBeat-2.8%—
BeatBeat-0.8%-2.8%
BeatBeat+6.3%+1.6%
BeatBeat-23.4%-31.0%
BeatBeat-5.0%-12.5%
BeatBeat+26.4%+39.2%
BeatBeat-1.5%+21.6%
BeatMiss-9.1%-7.9%
BeatBeat+32.0%+27.0%
BeatMiss-16.9%-7.7%
BeatBeat-11.3%-7.4%
——+12.8%+19.6%

Beating the estimate has not been enough: the stock fell after 8 of the last 11 beats. The bar it has to clear is the whisper number, not the published one.

What management is saying differently

Management's own words on the Q3 FY2026 call () against Q2 FY2026 (). Analysts' questions are left out.

  • New this call: “memory solutions”, “pcie gen”, “rack scale”, “growth opportunities” — none of them came up in Q2 FY2026.
  • Getting louder: “revenue growth” (3 → 6 mentions), “memory controllers” (2 → 5 mentions), “addressable market” (1 → 4 mentions).
  • Gone quiet: “volume production”, “gross margins”, “cosmos platform” — regular themes last call, absent this time.

The tone held steady from one call to the next; what changed is the subject matter, not the confidence.

Our track record on this stock

Since the score went from 87 to 87 while the share price moved -21.9% through .

MoonshotScore (0–100, band floors 45 · 65 · 80) Share price, scaled to its own range
Band changes, newest first. “Right” means the price moved the way the change pointed over the next three months.
DateBand3 months6 monthsCall
Strong → Exceptional———
Exceptional → Strong———
Strong → Exceptional———
Exceptional → Strong———
Strong → Exceptional———
Exceptional → Strong———

None of the 10 band changes we have recorded has been graded yet; we grade each band change three months after it happens.

The crowd against our signals

  • Analysts: 72% of 18 rate it a buy; the average target sits +67.6% from the price of $216.75.
  • Last 90 days: 1 upgrade and 0 downgrades among 9 rating actions.
  • Our signals: Exceptional band; strongest pillar Growth Durability (98), weakest Valuation (19).

Here we and the crowd agree. Where we differ is on price: our Valuation reading is more cautious than the analysts' targets.

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 18, 2026: low $112, high $417, latest $217. $417 $112 high $417 Oct 17, 2025 Nov 18, 2026 · $217 $160Oct 17, 2025$187Oct 31, 2025$144Nov 14, 2025$158Nov 28, 2025$149Dec 12, 2025$167Dec 26, 2025$163Jan 9, 2026$170Jan 23, 2026$170Feb 6, 2026$130Feb 20, 2026$119Mar 6, 2026$116Mar 20, 2026$117Apr 2, 2026$174Apr 17, 2026$203May 1, 2026$233May 15, 2026$343May 29, 2026$367Jun 12, 2026$392Jun 26, 2026$413Jul 10, 2026$292Jul 24, 2026$334Aug 7, 2026$285Aug 21, 2026$310Sep 4, 2026$303Sep 18, 2026$350Oct 2, 2026$286Oct 16, 2026$259Oct 30, 2026$222Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for Astera Labs, Inc. Common Stock (ALAB): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Strong
Financial Safety Strong
Valuation Negative
Growth Durability Strong
Momentum Neutral

Legends Council

6 lenses, 6 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Unfavorable read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Favorable read

Read on: Nov 20, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Strong
Margin of Safety Fairly Valued
Profit Margin Strong
Revenue Growth Strong
Debt/Equity Strong
ROE Strong
Gross Margin Strong

Read on: Nov 19, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

Two of these lenses read this company less favourably than the MoonshotScore does: Simons-style lens and Klarman-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

The Munger lens reads the current price as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Astera Labs, Inc. Common Stock (ALAB), and what does it report?

Short answer · as of

Astera sells connectivity products unified by a software-defined architecture, with demand tied to the deployment and scaling of cloud and artificial intelligence infrastructure.

Its economic role is moving data among compute, network and memory resources, which differs from the processor exposure commonly associated with semiconductor companies.

Reported revenue is consolidated into a reportable segment, so the accounts show platform-wide sales without revealing revenue by product family. The annual and quarterly series therefore measure the expansion of the overall connectivity franchise, not the separate contribution of Scorpio, Leo or other product lines.

2 · Latest results

What do the latest results show for Astera Labs, Inc. Common Stock (ALAB)?

The latest results extended a steep sequential expansion: revenue, gross profit, operating profit, net income and diluted earnings per share all advanced. Operating cash flow also remained positive, while research and development spending climbed as Astera funded its product roadmap. The release continued a run in which reported revenue and earnings surpassed market expectations.

Management attributed the next phase to Scorpio X-Series volume production and expects the Scorpio family to become the largest product category by revenue. Its outlook calls for another sizable revenue step-up but a lower gross margin than the latest reported level, making product mix and ramp economics as important as headline growth.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2025$231M$91M$0.50 (diluted)
Q4 FY2025$271M$45M$0.25 (diluted)
Q1 FY2026$308M$80M$0.44 (diluted)
Q2 FY2026$392M$153M$0.83 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Astera Labs, Inc. Common Stock (ALAB)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

Astera carries no debt, holds a large cash and short-term investment balance, and has increased that balance across the reported history. Operating cash flow has stayed positive, with capital spending remaining below operating cash generation, giving the company room to support rising research and development expenditure without balance-sheet strain.

The equity valuation is far less forgiving than the finances: market value stands far above net cash, while earnings and free-cash-flow yields remain thin. A slowdown in cloud and artificial intelligence infrastructure deployment, disappointing Scorpio adoption, or continued gross-margin compression could expose how much growth is embedded in that valuation.

Data-derived red flags

  • Inconsistent delivery — missed Wall Street EPS estimates in 0 of the last 4 reported quarters.
  • Rich valuation — a P/E of 78.96 runs well above the Technology sector’s ~28.90x, leaving little room for a miss.
4 · What to check next?

What should you watch next at Astera Labs, Inc. Common Stock (ALAB)?

Short answer · as of

Current published price targets run low $275.00 · high $500.00 · consensus $363.36 · median $325.00 against a quoted price of $216.75 (as of Nov 18, 2026).

Scorpio’s promised transition into Astera’s largest product category is the most concrete product-mix checkpoint. Readers should compare reported revenue with management’s outlook, then examine whether the expected gross-margin decline is temporary mix pressure or persists as volume expands.

Research and development is rising quickly, so operating leverage and cash conversion deserve attention alongside sales. Farther out, volume shipments of standard and custom Leo CXL memory controllers to U.S. hyperscalers would demonstrate that Astera can extend its connectivity platform across general-purpose computing and artificial intelligence inference; the wide range of longer-horizon revenue estimates reinforces the need for product evidence.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Astera Labs, Inc. Common Stock compare with its peers?

Short answer

Astera Labs, Inc. Common Stock's score ranks 3rd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Processor vendors monetize the engines performing computation; Astera monetizes the links joining compute, network and memory resources. Its products share a software-defined architecture, giving customers a connectivity platform rather than an isolated chip function.

Astera also reports its operations as a consolidated segment, unlike diversified semiconductor businesses whose segment accounts expose separate end markets. That makes product milestones such as Scorpio becoming the largest revenue category and Leo entering hyperscaler volume production unusually important for interpreting the mix.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
SanDisk Corp. (SNDK) Named competitor$776.22 Nov 18, 2026$110B99 5-pillar Nov 18, 2026
Teradyne, Inc. (TER) Named competitor$235.21 Nov 18, 2026$36.7B91 5-pillar Nov 18, 2026
Astera Labs, Inc. Common Stock (ALAB) — this page$216.75$37.9B87
Monolithic Power Systems, Inc. (MPWR) Same industry, near in market value$1310.91 Nov 18, 2026$63.9B82 5-pillar Nov 18, 2026
United Microelectronics Corporation (UMC) Same industry, near in market value$13.96 Nov 18, 2026$35.0B81 5-pillar Nov 18, 2026
ASE Technology Holding Co., Ltd. (ASX) Named competitor$32.53 Nov 18, 2026$71.8B77 5-pillar Nov 18, 2026
Keysight Technologies, Inc. (KEYS) Named competitor$286.30 Nov 18, 2026$48.7B77 5-pillar Nov 18, 2026
NXP Semiconductors N.V. (NXPI) Same industry, near in market value$252.47 Nov 18, 2026$63.6B77 5-pillar Nov 18, 2026
Entegris, Inc. (ENTG) Same industry, near in market value$143.78 Nov 18, 2026$22.0B67 5-pillar Nov 18, 2026
Hewlett Packard Enterprise Company (HPE) Named competitor$45.78 Nov 18, 2026$60.8B65 5-pillar Nov 18, 2026
STMicroelectronics N.V. (STM) Same industry, near in market value$44.91 Nov 18, 2026$40.1B65 5-pillar Nov 18, 2026
ON Semiconductor Corporation (ON) Same industry, near in market value$67.23 Nov 18, 2026$26.2B65 5-pillar Nov 18, 2026
Microchip Technology Incorporated (MCHP) Same industry, near in market value$59.67 Nov 18, 2026$32.5B61 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Technology stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$275.00 – $500.00
Consensus target
$363.36
Median target
$325.00

Consensus record · Captured .

Measured against a quoted price of $216.75 (as of Nov 18, 2026).

Insider activity

Form 4 records via FMP · Of the newest 500 records, those within the last 180 days, newest dated Nov 5, 2026

Transactions
221
Identified insiders
10
Purchases
0
Sales
212
Other transactions
9

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held ALAB in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported ALAB in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

Common Questions About ALAB (Technology)

The last 2 questions are answered from this page's own dated data, not from the research.

Why can Astera Labs grow without selling artificial intelligence processors?

Artificial intelligence systems require data to move among processors, memory and networks, and Astera sells the semiconductor-based connectivity that supports those paths. Its demand therefore rises with the scale and complexity of deployed infrastructure, even though it does not sell the compute engines themselves.

What would make Scorpio X-Series important to Astera Labs?

Reaching that milestone would confirm a material shift in product mix during a period of rapid company-wide growth.

Where do Leo CXL memory controllers fit in Astera Labs?

Leo extends Astera’s platform into memory connectivity for general-purpose computing and artificial intelligence inference. Management expects standard and custom controllers to ship in volume to U.S. hyperscalers, making customer deployment the relevant proof point.

Can Astera Labs fund its connectivity roadmap from its own balance sheet?

The company has substantial cash and short-term investments, no debt and positive operating cash generation across the reported period. That capacity supports rising research and development spending, though sustained cash conversion remains important as product investment and capital spending increase.

What is the ALAB stock price today?

The last price recorded for Astera Labs, Inc. Common Stock (ALAB), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the ALAB price target?

The analyst consensus price target for Astera Labs, Inc. Common Stock (ALAB), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Reviewed by Sedat ANAK, Founder and Editor-in-Chief, on 2026-11-07.

Sources: the source register lists the 26 figures on this page — 1 from SEC filings and earnings calls, 20 from Financial Modeling Prep (FMP), 3 with no recorded source and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-13), by section of the research

  • Summary at the top of the page: Business description; Quarterly income statement (USD thousands); Trailing twelve-month ratio set; Management outlook — dated call excerpts
  • 1. What is Astera Labs, Inc. Common Stock (ALAB), and what does it report?: Business description; Sector / industry (provider taxonomy); Revenue by segment; Annual revenue and net result (USD millions); Quarterly income statement (USD thousands)
  • 2. What do the latest results show for Astera Labs, Inc. Common Stock (ALAB)?: Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Operating cash flow by quarter (USD millions); Reported versus estimated, last 8 quarters; Most recent periodic reports; Management outlook — dated call excerpts
  • 3. What are the financial strengths and risks for Astera Labs, Inc. Common Stock (ALAB)?: Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Operating cash flow by quarter (USD millions); Cash against market value; Trailing twelve-month ratio set
  • 4. What should you watch next at Astera Labs, Inc. Common Stock (ALAB)?: Management outlook — dated call excerpts; Next earnings report; Analyst revenue and earnings estimates (average); Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Reported versus estimated, last 8 quarters
  • 5. How does Astera Labs, Inc. Common Stock compare with its peers?: Business description; Sector / industry (provider taxonomy); Revenue by segment; Management outlook — dated call excerpts
  • FAQ: Why can Astera Labs grow without selling artificial intelligence processors?: Business description; Annual revenue and net result (USD millions); Quarterly income statement (USD thousands)
  • FAQ: What would make Scorpio X-Series important to Astera Labs?: Management outlook — dated call excerpts; Quarterly income statement (USD thousands); Reported versus estimated, last 8 quarters
  • FAQ: Where do Leo CXL memory controllers fit in Astera Labs?: Business description; Management outlook — dated call excerpts
  • FAQ: Can Astera Labs fund its connectivity roadmap from its own balance sheet?: Cash, investments and debt; Cash and short-term investments over time (USD millions); Operating cash flow by quarter (USD millions); Quarterly income statement (USD thousands)
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.